A Real-world, Head-to-head Comparison of Dupilumab Versus Mepolizumab in Danish Patients With Chronic Rhinosinusitis With Nasal Polyps (TORNADO)
Treatment of Rhinosinusitis With Nasal Polyposis With Dupilumab and Mepolizumab: A Randomized, Multi-centre, Head-to-head Comparison in Real-world Danish Patients
Sponsor: Rigshospitalet, Denmark
Listed as NCT05942222, this PHASE4 trial focuses on Asthma; Eosinophilic and Chronic Rhinosinusitis With Nasal Polyps and remains ongoing. Sponsored by Rigshospitalet, Denmark, it has been updated 4 times since 2023, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
4 versions recorded-
Aug 2025 — Present [monthly]
Active Not Recruiting PHASE4
Status: Recruiting → Active Not Recruiting
-
Sep 2024 — Aug 2025 [monthly]
Recruiting PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE4
-
Aug 2023 — Jul 2024 [monthly]
Recruiting PHASE4
First recorded
Apr 2023
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Rigshospitalet, Denmark
For direct contact, visit the study record on ClinicalTrials.gov .